Skip to content

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Americas72.1%-0.1%
Europe, Middle East, and Africa (“EMEA”)15.8%+0.6%
Asia Pacific (“APAC”)12.1%0.0%

By product

See full
Service1%0.0%

Other financials

Income statement

See full
Revenue$1.2B+5.5%
Gross profit$964.7M+7.6%
Operating income$310.5M+28.5%
Net income$425.7M+67.2%
EPS (diluted)$1.42+75.3%

Balance sheet

See full
Cash & equivalents$930.9M-25.3%
Total debt$60.2M-2.1%
Total equity$10.0B+12.0%
Total assets$12.2B+11.0%

Cash flow

See full
Operating cash flow$521.6M+6.6%
CapEx$21.1M-18.5%
Free cash flow$500.5M+8.0%

Valuation

See full
Market cap$25.36B+9.6%
Enterprise value$24.49B+11.6%
P/E12.2×-9.8×
P/S5.1×+0.2×

Profitability

See full
Gross margin77.4%+1.5pp
Operating margin24.2%+6.0pp
Net margin42%+19.7pp
FCF margin39.8%+3.5pp

Returns & leverage

See full
Return on equity21.9%+9.8pp
Debt / equity0.0×
Current ratio4.2×-0.3×